Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials (Q56944618)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

meta-analysis

0 references

title

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

main subject

meta-analysis

0 references

acute coronary syndrome

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Paul W. Armstrong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Eric J. Topol

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

12

Robert M Califf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

4

Harvey White

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

10

Robert G Wilcox

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

5

Pierre Théroux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1

Eric Boersma

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Maarten L Simoons

14

object named as

Maarten L Simoons

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Anneke de Torbal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Lars C Wallentin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

John Simes

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Robert A Harrington

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

David J Moliterno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

English

0 references

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

189-198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

9302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907442-1

7 January 2021

10.1016/S0140-6736(02)07442-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11812552%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference